2 
Other National Institutes of Health staff present were; 
Dr. Marilyn Bach, NIAID; Dr. Stanley Barban, NIAID; Dr. W. Elunett Barld.ey, QRS; 
Mrs. Betty Butler, NIAID; Ms. Mary Donovan, NIAID; Dr. John Irwin, ORS; 
Dr. Richard Krause, NIAID; Dr. Elizabeth Milewski, NIAID; Dr. Stanley Nagle, 
NIAID; Dr. John Nutter, NIAID; Dr. Bernard Talbot, OD; and Dr. Rudolf Wanner, 
ORS, 
Others in attendance for all or part of the meeting were; 
Dr. E. A. Agostini, Pfizer, Inc.; Dr. Bay Berger, Schering-Plough Corp.; 
Ms. Irene Brandt, Eli Lilly & Co.; Dr. Peter Bostock, New Brunswick Scientific 
Co.; Dr. Jerry Callis, U. S. Department of Agriculture, Plum Island; Dr. Aileen 
Gcnpton, Smith-Kline & French; Mr. L. Curley, New Brunswick Scientific Co.; 
Dr. Mark Finkelstein, Schering-Plough Corp.; Dr. Patrick Gage, Hoffinan LaRoche, 
Inc.; Ms. Lizabeth Qelber, Bokon Productions; Dr. Jean Gudas, Ikiiversily of 
California, Los Angeles; Dr. Paul Hung, Abbott Research Laboratories; Dr. James 
Hunt, Chemapec; Dr. Dorothy Jessup, U. S. Department of Agriculture; 
Dr. Attila I. Kadar, Food and Drug Administration; Mr. W. H. Kampen, New 
Brunswick Scientific Co.; Mr. Geoffrey Kamy, Office of Technology Assessment; 
Dr. Paul Leibowitz, Schering-Plough Corp.; Ms. Carter Leonard, Blue Sheet; 
Mr. Ronald Leonard!, KABI Group, Inc.; Mr. Charles Marwick, M^ical World 
News; Dr. James McCullough, Library of Congress; Mr. Bing Miller, New Brunswick 
Scientific Co.; Dr. Henry Miller, Food and Drug Administration; Dr. Philip 
Miller, Hoffinran LaRoche, Inc.; Dr. Ann Norberg, Monsanto Co.; Mr. Seth Pauker, 
Nation^ Institute for Occupational Safety and Health; Dr. Stephen Pi jar. 
Pood and Drug Administration; Dr. Vishva Rai, Hof finnan LaRoche, Inc.; 
Dr. Michael Ross, Genentech, Inc.; Mr. Dan Smith, Peoples Business Commission; 
Mr. Charles Turbyville, Genetic Engineering Letter; Dr. Marvin Weinstein, 
Schering-Plough, Corp.; Dr. Susan Wright, University of Michigan; Dr. Bill 
Young, Genentech, Inc.; and Dr. Robert Zaugg, Teknekron, Inc. 
I. CALL TO ORDER AND OPENING REMARKS 
Mr. Ray Ihomton, Chairman, called the meeting to order at 9:00 a.m., 
January 8, 1981. He introduced two newly appointed manbers of the 
committee; Dr. King Holmes of the Division of Infectious Diseases of the 
U.S. Public Health Service Hospital, Seattle, Washington and Dr. Robert 
McKinney of the Division of Safety of the National Institutes of Health 
(NIH) . 
Mr. Itiombon said he had asked Dr. McKinney to serve as co-chairman, 
with Dr. Bems, of the newly instituted Large-Scale Review Working Group. 
Mr. Ihomton said that any RAC member interested in servit^ on that 
working group should contact him. 
[301 
